The local intravenous fluids manufacturer Gulf Inject announced it
has signed a distribution agreement with the UAE-based healthcare leader
Zulekha
Dubai, United Arab Emirates.-Thursday, August 10th 2017 [ AETOS Wire ]
Gulf
Inject, a Julphar company - the region’s leading pharmaceutical
manufacturer, has announced it has signed a local distribution agreement
with Zulekha Healthcare Group.
The business milestone event was held at the Gulf Inject manufacturing facility located in the Jebel Ali Free Zone, Dubai in the presence of dignitaries and representatives from both companies.
Launched in 1994, Gulf Inject produces world-class intravenous (IV) fluids and has established itself as a regional leader in fluid management. The facility was upgraded in 2013 to comply with current GMP requirements and its local partnership agreement with Zulekha Healthcare Group is expected to positively impact current business in the UAE.
Commenting on the distribution agreement, Gulf Inject’s General Manager Dr Ashraf Abu Arrah said: “Our vision is to be a leader in the formulation of sterile solutions in the region and I strongly believe that our newly-signed distribution agreement with the well-established healthcare service provider Zulekha will help us achieve our goal and better serve the local healthcare community.”
“The agreement will tremendously change the existing business environment,” added Anubhav Gautam, Managing Director at Royal Care Medical and Channel Partner Zulekha Store. “Gulf inject is a market leader in its product range and Zulekha is well-known in the GCC in the supply chain management field. This partnership can only benefit both parties by bringing in new synergy and stability in their respective business.”
About Gulf Inject
Gulf Inject is a subsidiary company of Julphar - the region’s leading pharmaceutical manufacturer. Gulf Inject is one of the major manufacturers of healthcare solutions in the United Arab Emirates. Its in-house capabilities of extensive technologies and manufacturing capacities are part of its strengths and its strong regulatory knowledge makes Gulf Inject a partner of choice in the pharmaceutical industry. With its constantly growing portfolio of effective medical care solutions, Gulf Inject makes a substantial contribution towards protecting and improving people’s health.
About Zulekha Healthcare Group
Zulekha Healthcare Group is a leading healthcare brand with multi-specialty hospitals, offering cardiac care, intensive care unit and neonatal intensive care unit facilities in diagnostic set-ups located in Dubai and Sharjah. The Group provides patient care and best services under the guidance of its visionary leader, Dr Zulekha Daud. Zulekha Healthcare Group employs over 1,500 professionals to complement its state-of-the-art infrastructure. It provides specialized treatments in over 25 disciplines, ranging from gynecology to challenging procedures in interventional cardiology.
Contacts
Prabhakaran Sineesh
Plant Manager Gulf Inject, +971503138747
Email: prabhakaran.sineesh@gulfinject.com
Permalink : http://aetoswire.com/news/4376/en
Dubai, United Arab Emirates.-Thursday, August 10th 2017 [ AETOS Wire ]
Gulf
Inject, a Julphar company - the region’s leading pharmaceutical
manufacturer, has announced it has signed a local distribution agreement
with Zulekha Healthcare Group.The business milestone event was held at the Gulf Inject manufacturing facility located in the Jebel Ali Free Zone, Dubai in the presence of dignitaries and representatives from both companies.
Launched in 1994, Gulf Inject produces world-class intravenous (IV) fluids and has established itself as a regional leader in fluid management. The facility was upgraded in 2013 to comply with current GMP requirements and its local partnership agreement with Zulekha Healthcare Group is expected to positively impact current business in the UAE.
Commenting on the distribution agreement, Gulf Inject’s General Manager Dr Ashraf Abu Arrah said: “Our vision is to be a leader in the formulation of sterile solutions in the region and I strongly believe that our newly-signed distribution agreement with the well-established healthcare service provider Zulekha will help us achieve our goal and better serve the local healthcare community.”
“The agreement will tremendously change the existing business environment,” added Anubhav Gautam, Managing Director at Royal Care Medical and Channel Partner Zulekha Store. “Gulf inject is a market leader in its product range and Zulekha is well-known in the GCC in the supply chain management field. This partnership can only benefit both parties by bringing in new synergy and stability in their respective business.”
About Gulf Inject
Gulf Inject is a subsidiary company of Julphar - the region’s leading pharmaceutical manufacturer. Gulf Inject is one of the major manufacturers of healthcare solutions in the United Arab Emirates. Its in-house capabilities of extensive technologies and manufacturing capacities are part of its strengths and its strong regulatory knowledge makes Gulf Inject a partner of choice in the pharmaceutical industry. With its constantly growing portfolio of effective medical care solutions, Gulf Inject makes a substantial contribution towards protecting and improving people’s health.
About Zulekha Healthcare Group
Zulekha Healthcare Group is a leading healthcare brand with multi-specialty hospitals, offering cardiac care, intensive care unit and neonatal intensive care unit facilities in diagnostic set-ups located in Dubai and Sharjah. The Group provides patient care and best services under the guidance of its visionary leader, Dr Zulekha Daud. Zulekha Healthcare Group employs over 1,500 professionals to complement its state-of-the-art infrastructure. It provides specialized treatments in over 25 disciplines, ranging from gynecology to challenging procedures in interventional cardiology.
Contacts
Prabhakaran Sineesh
Plant Manager Gulf Inject, +971503138747
Email: prabhakaran.sineesh@gulfinject.com
Permalink : http://aetoswire.com/news/4376/en
No comments:
Post a Comment